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The prevalence of hypertension in African Americans (AAs) is higher than in other US groups; yet, few have per-
formed genome-wide association studies (GWASs) in AA. Among people of European descent, GWASs have
identified genetic variants at 13 loci that are associated with blood pressure. It is unknown if these variants
confer susceptibility in people of African ancestry. Here, we examined genome-wide and candidate gene associ-
ations with systolic blood pressure (SBP) and diastolic blood pressure (DBP) using the Candidate Gene
Association Resource (CARe) consortium consisting of 8591 AAs. Genotypes included genome-wide single-
nucleotide polymorphism (SNP) data utilizing the Affymetrix 6.0 array with imputation to 2.5 million HapMap
SNPs and candidate gene SNP data utilizing a 50K cardiovascular gene-centric array (ITMAT-Broad-CARe
[IBC] array). For Affymetrix data, the strongest signal for DBP was rs10474346 (P 5 3.6 3 1028) located near
GPR98 and ARRDC3. For SBP, the strongest signal was rs2258119 in C21orf91 (P 5 4.7 3 1028). The top IBC
association for SBP was rs2012318 (P 5 6.4 3 1026) near SLC25A42 and for DBP was rs2523586 (P 5 1.3 3
1026) near HLA-B. None of the top variants replicated in additional AA (n 5 11 882) or European-American
(n 5 69 899) cohorts. We replicated previously reported European-American blood pressure SNPs in our AA
samples (SH2B3, P 5 0.009; TBX3-TBX5, P 5 0.03; and CSK-ULK3, P 5 0.0004). These genetic loci represent
the best evidence of genetic influences on SBP and DBP in AAs to date. More broadly, this work supports that
notion that blood pressure among AAs is a trait with genetic underpinnings but also with significant complexity.
INTRODUCTION
In the USA, hypertension is more common among people of
African compared with European descent. According to data
from the National Health and Nutrition Examination Survey
(NHANES) collected between 1999 and 2004, the prevalence
of hypertension in African Americans (AAs) was 40%, com-
pared with 27% in European Americans (1,2). The risk of suf-
fering hypertensive end-organ damage including end-stage
renal disease, heart failure and stroke is also greater among
AAs than European Americans (1,3). Furthermore, in 2004,
the death rate from hypertension was three times greater in
AAs compared with European Americans (4,5).
A portion of the excess burden of hypertension among AAs
may be due to genetic susceptibility. Admixture mapping analy-
sis of hypertension suggested that African ancestry is associated
with hypertension (6). Two recent genome-wide association
studies (GWASs) of blood pressure, each involving 30 000
participants of European descent, have identified common
genetic variants at 13 loci that are associated with blood pressure
or hypertension. It is unknown at present, however, if these var-
iants confer susceptibility to hypertension in people of African
descent. Prior investigations have reported considerable differ-
ences in genetic association patterns for blood pressure and
other traits across ethnic/racial groups. These association differ-
ences may be due to differences in linkage disequilibrium (LD)
patterns, allele frequencies, causal pathways, or environmental
exposures. Therefore, the relations of genetic variants to blood
pressure must be examined within ethnicities.
The first GWAS for blood pressure phenotypes in AAs did not
identify any SNPs reaching genome-wide significance (P, 5 ×
1028) with hypertension, although six were associated with sys-
tolic blood pressure (SBP) in a secondary analysis in a subset of
508 normotensive individuals (7). The present study represents
the largest GWAS for blood pressure in AAs to date. We also
attempted replication of our top findings in individuals of
African ancestry and individuals of European ancestry. Under-
standing genetic contributions to blood pressure may provide
insight into the mechanisms underlying ethnic disparities in car-
diovascular disease, and findings may assist in more personalized
and targeted treatments to prevent target-organ damage and its
associated morbidity and mortality.
RESULTS
Study sample
The analyzed study sample included individuals from five
cohorts [Atherosclerosis Risk in Communities (ARIC) study
(n ¼ 2511); Coronary Artery Risk Development in Young
Adults (CARDIA, n ¼ 833); Cleveland Family Study (CFS,
n ¼ 489), Jackson Heart Study (JHS, n ¼ 2017) and Multi-
Ethnic Study of Atherosclerosis (MESA, n ¼ 1623); total
n ¼ 7473] for the GWAS analysis and six cohorts [ARIC
(n ¼ 2692), CARDIA (n ¼ 1134), CFS (n ¼ 530), Cardiovas-
cular Health Study (CHS; n ¼ 735), JHS (n ¼ 1916) and
MESA (n ¼ 1584); total n ¼ 8591)] for the IBC analysis.
For JHS, we excluded these individuals who were overlapped
with ARIC participants. The cohort-specific sample character-
istics are described in Table 1.
Genome-wide association of Candidate Gene Association
Resource AA cohorts for blood pressure
Meta-analysis quantile–quantile and Manhattan plots of
genome-wide SNPs including both genotyped and imputed
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for the two blood pressure phenotypes are presented in Sup-
plementary Material, Figure S1. If an SNP was genotyped,
we always reported the result based on genotyped data. In
the meta-analysis of GWAS data, one SNP for diastolic
blood pressure (DBP) and one for SBP attained genome-wide
significance (defined as P , 5 × 1028; Table 2). The strongest
signal for DBP was rs10474346 (P ¼ 3.6 × 1028) in the inter-
genic region of GPR98 and ARRDC3 on chromosome 5q14.
This SNP is in tight LD with a missense SNP (rs4377733;
pairwise r2 ¼ 0.9) in hypothetical gene LOC729040. For
SBP, the strongest signal was for rs2258119 in C21orf91 on
chromosome 21q21 (P ¼ 4.7 × 1028), which is in tight LD
with nearby rs2824495 (r2 ¼ 1.0), which is a missense SNP
in C21orf91. Suggestive evidence of association was detected
in the regions of IPO13 (rs1990151, P ¼ 7.4 × 1027), FMNL2
(rs13413144, P ¼ 5.6 × 1027) and GPD2 (rs592582, P ¼
4.5 × 1027). The regional plots of association for the genome-
wide significant loci are presented in Figure 1.
Pooled genotype data analysis was conducted for the five
cohorts with Affymetrix 6.0 genotyping data using FamCC
(8), on genotyped SNPs only. In general, the results were
highly consistent with those from the meta-analysis.
Association of SNPs on the IBC chip with blood pressure
Meta-analysis of Candidate Gene Association Resource
(CARe) cohorts with IBC chip data did not identify any
SNPs that reached the pre-specified array-wide significance
level based on the estimated effective number of independent
tests (SNPs) after adjusting for multiple testing (0.05/25 000,
P , 2.0 × 1026). There was suggestive evidence of associ-
ation with SBP for two genes NUCB2 (rs214070, P ¼
8.7 × 1026; in LD with missense SNP rs757081, r2 ¼ 0.7)
and SLC25A42 (rs2012318, P ¼ 6.4 × 1026; in LD with mis-
sense SNP rs4808907, in SFRS14, r2 ¼ 0.6); these results are
summarized in Table 3. The top results for DBP were
rs2523586 (near HLA-B, P ¼ 1.3 × 1026) and rs4930130
(near KCNQ1, P ¼ 3.2 × 1026). These and other SNPs
with P , 1024 are summarized in Supplementary Material,
Table S3.
Independent replication of top CARe SNPs in cohorts of
African and European ancestry
Replication cohorts for the study are described in detail in
Supplementary Material, Section II. Nine top SNPs (six
selected from the genome-wide meta-analysis, two selected
from the candidate gene meta-analysis and one selected
from the CARDIA GWAS) in the CARe analyses were sub-
mitted for lookup in five AA cohorts [Maywood
African-American study (n ¼ 743), Howard University
Family Study (HUFS, n ¼ 1016), the International Collabora-
tive Study on Hypertension in Blacks (ICSHIB, n ¼ 1188), the
Genetic Epidemiology Network of Arteriopathy (GENOA,
n ¼ 845) and the Women Health Initiative (WHI, n ¼ 8090)]
and in whites of European ancestry in the International Con-
sortium for Blood Pressure (ICBP; n ¼ 69 899). Criteria for
declaring replication was either 5.0 × 1028 for final
meta-analysis of GWAS SNPs or 2.0 × 1026 for final
meta-analysis of IBC SNPs. Results of replication for SBP
and DBP by replication cohort and those of the final
meta-analysis of cohorts of African ancestry are provided in
Table 4. None of the top SNPs from the Affymetrix 6.0 or
the IBC array met the a priori criteria for replication after cor-
recting for multiple comparisons. Results of replication by
cohort are displayed in Supplementary Material, Table S4.
Lookup of published SNPs from previous studies of people
with African ancestry
We examined whether published SNPs from GWAS of blood
pressure in people of African ancestry (9) could be replicated
in our sample (Supplementary Material, Table S2A). None of
the previously reported loci for SBP or DBP replicated in our
study.
Lookups of published SNPs from previous studies
including populations of European ancestry
Two large-scale GWASs in European populations have been
published, and 13 independent loci have been shown to be
associated with blood pressure at a genome-wide significant
Table 1. Study sample characteristics
Study N Male
(%)
Antihypertensive
medication (%)
Age (years) BMI (kg/m2) DBP (mmHg) SBP (mmHg)
Mean SD Mean SD Mean SD Mean SD
Affymetrix 6.0 genotyping
ARIC 2511 37.1 44.0 53.3 5.8 29.6 6.0 79.7 12.1 128.3 20.8
CARDIA 833 38.1 13.0 39.5 3.9 30.8 7.5 76.9 12.1 116.9 16.4
CFS 489 40.7 38.9 45.7 16.2 34.6 9.6 76.5 10.7 128.2 16.0
JHS 2017 38.7 46.3 49.9 11.9 32.3 7.8 80.0 10.6 124.9 18.0
MESA 1623 45.7 50.5 62.2 10.1 30.2 5.9 74.5 10.2 131.4 21.7
IBC genotyping
ARIC 2692 36.9 44.1 53.2 5.8 29.7 6.1 79.4 12.0 128.0 20.7
CARDIA 1134 40.5 13.8 39.6 3.8 30.7 7.5 77.0 12.4 117.1 16.3
CFS 530 42.1 37.7 45.2 16.1 34.2 9.6 76.4 10.8 127.7 15.8
CHS 735 37.6 51.8 73.0 5.7 28.5 5.6 75.1 11.3 141.8 22.7
JHS 1916 39.2 46.0 49.9 12.0 32.2 7.8 79.9 10.6 124.9 18.0
MESA 1584 46.1 50.9 62.2 10.1 30.2 5.9 74.6 10.3 131.7 21.6
Study characteristics are shown for cohort samples examined in meta-analysis. N, sample size—the number of individuals with genotype and phenotype data
available.
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level (10,11). We then performed one-sided test to examine if
the association evidence for these published loci can be repli-
cated in the CARe data sets. The one-sided test ensures the
effect directions are the same in both discovery and replication
samples. Of the SNPs reported in these two European GWASs
(Table 5 and Supplementary Material, Tables S2A and S2B),
we identified the following association signals in our AA
samples: rs3184504 (SH2B3, one-sided P ¼ 0.009),
rs2384550 (TBX3-TBX5, one-sided P ¼ 0.03) and rs6495122
(CSK-ULK3, one-sided P ¼ 0.0004).
DISCUSSION
This study represents the largest GWAS of blood pressure in
AAs to date including a total of 8591 individuals for discovery
and 11 882 individuals of African descent and 69 899 of Euro-
pean descent for replication. In a meta-analysis across five US
community-based cohorts using the Affymetrix 6.0 array, we
identified two novel loci, rs2258119 and rs10474346, that
reached genome-wide significance, but did not replicate in
independent African-American samples. We replicated
several previously reported European-American blood
pressure SNPs in our CARe AA samples.
Top loci for the Affymetrix 6.0 array GWAS
We identified a locus on chromosome 5 that reached genome-
wide significance for DBP in CARe African-American
cohorts. The top SNP (rs10474346, P ¼ 3.6 × 1028) is in
tight LD with a non-synonymous coding SNP rs4377733.
Genes in the region include G protein-coupled receptor 98
(GPR98) and arrestin C (ARRDC3). GRR98 is a very large
G-protein coupled receptor expressed in the central nervous
system and other tissue and implicated in Usher syndrome
characterized by hearing loss and retinitis pigmentosa. SNPs
in GPR98 have been associated with markers of hyperglyce-
mia in patients taking the antipsychotic medication olanzapine
(12). Arrestin C is a peroxisome proliferator-activated receptor
gamma (PPARG) ligand and PPARG activator. PPARs are a
family of nuclear receptors that are activated by nutrient mol-
ecules and their derivatives (13). PPARG activators may play
a role in hypertension and atherosclerosis through modifi-
cation of inflammation and the innate immunity system in vas-
cular cells (13,14).
Another locus that reached genome-wide significance for
SBP in CARe AA cohorts is on chromosome 21, where a
region was previously reported in admixture mapping analysis
(15). The top SNP at this locus, rs2258119 (P ¼ 4.7 × 1028),
is in tight LD with missense variant rs2824495 in C21orf91
(pairwise r2 ¼ 1.0). The minor allele frequencies of this
SNP in HapMap CEU and YRI samples are 21 and 34%,
respectively, which suggests that this SNP may contribute to
the association signal observed in the admixture mapping
analysis (15). This region includes CXADR (Coxsackie and
Adenovirus receptors), which encodes a tight junction
protein of the intercalated disks between cardiomyocytes.
This protein is an entry point for virus uptake in myocarditis
and is involved in cardiac remodeling (16). An SNP of inter-
est, rs1990151 on chromosome 1, showed suggestiveT
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association with SBP (P ¼ 7.4 × 1027). This is an intronic
SNP in importin beta (IPO13). Importin beta is a nuclear
transport protein that modifies nuclear availability of glucocor-
ticoids through nucleocytoplasmic shuttling (17). There is a
potential link proposed between early-onset glucocorticoid
exposure and hypertension through changes in gene expression
and function in the kidney (18). Of note, another importin beta
protein (IPO7) was identified by Adeyemo et al. (7) in a
genome-wide association analysis of a normotensive subset
of AAs.
Top SNPs from the meta-analysis of the IBC array
In our IBC array analysis, we identified suggestive evidence of
association for rs2012318, which is an intronic SNP in
SLC25A42, a carrier protein that transports cofactor coenzyme
A and adenosine 3′,5′-diphosphate into the mitochondria in
exchange for intramitochondrial (deoxy)adenine nucleotides
and adenosine 3′,5′-diphosphate (19). SNPs in this region
were associated with LDL cholesterol and triglyceride
levels in a whole genome analysis of European populations
(20).
Two tightly linked SNPs, rs4930130 and rs1791926 (r2 ¼
1.0) on chromosome 11, were associated with DBP with
P , 1 × 1025. They are in proximity to KCNQ1, which
encodes a protein for a voltage-gated potassium channel
required for the repolarization phase of the cardiac action
potential. The gene product is associated with hereditary
long QT syndrome, Romano-Ward syndrome, Jervell and
Lange-Nielsen syndrome and familial atrial fibrillation (21).
Another signal of interest was found for rs1791926, near
P2RY2 (purinergic receptor P2Y, G coupled 2) on chromo-
some 11q13.5-q14.1 that mediates vasoactive and proliferative
stimuli. There is evidence that the purinergic system may
affect the activity of epithelial sodium channel in the renal col-
lecting duct, which is responsible for re-absorption of sodium
(22,23). Genetic defects in this channel in humans have been
associated with hypertension in Liddle’s syndrome. P2Y2 (a
homolog of P2RY2) knockout mice manifest a salt resistant
hypertensive phenotype (24). A recent case–control associ-
ation study by Wang et al. (25) showed an association of
P2RY2 with hypertension in Japanese men.
Association evidence of SNPs with blood pressure in
CARDIA
It is intriguing that we observed a strong association signal in a
1.26 Mb region on chromosome 11 (smallest P ¼ 3.95 × 1029
for rs17610514; Supplementary Material, Table S1) in AAs in
the CARDIA cohort only. Although the allele frequencies for
these significant SNPs are all relatively small (,4%), the
results are unlikely due to the genotyping errors given the
number of SNPs reaching genome-wide significance. The sen-
tinel SNP is in tight LD with several missense variants in
olfactory receptor genes. The subjects recruited in CARDIA
cohort are much younger than in the other cohorts, suggesting
that the association is stronger in populations composed of
younger individuals.
A particularly important contribution of this study is the gen-
eralization of findings from two large meta-analyses of Eur-
opeans and European Americans (10,11) to individuals of
African ancestry. The three loci, near the SH2B3, TBX3-TBX5
and CSK-ULK3 genes, provide evidence for common genetic
variants influencing blood pressure phenotypes in AA and also
suggest that at least some loci may confer broad susceptibility
to hypertension across race/ethnicities.
Figure 1. Regional plots of top blood pressure loci in AAs from meta-analysis
of Affymetrix 6.0 arrays. One locus for diastolic BP (A) and two loci for SBP
(B and C). For each locus, we show the region extending to within 500 kb of
the associated SNP on either side. Statistical significance of SNPs around each
locus are plotted as 2log10(P) against chromosomal position. For each locus,
the most significant SNP is shown in blue. If the most significant SNP of a
locus is imputed SNP (as in A), then the most significant genotype SNP is
shown in blue too. Among genotyped SNPs, SNPs in yellow have r2 ≥ 0.8
with the most significant genotyped SNP. Imputed SNPs are shown in grey.
Superimposed on the plot are gene locations (green) and recombination rate
(blue). Chromosome positions are based on HapMap release 22 build 36.
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Limitations
Because multiple cohorts were used to maximize the sample
size in the analyses, heterogeneity in blood pressure measure-
ment across the centers may bias our findings toward the null.
Additionally, a substantial proportion of individuals were on
blood pressure lowering medications, which may introduce
some degree of misclassification of blood pressure. In addition,
participants in JHS and ARIC were older with a large number on
antihypertensive medications, whereas participants in CARDIA
were significantly younger than the other cohorts with only a
small percentage of participants on antihypertensive medi-
cations. We observed some evidence for heterogeneity across
studies, with SNPs in GPR98 region (for DBP) on the Affyme-
trix 6.0 array (Table 2) and SNPs in the SLC25A42 region (for
both DBP and SBP) on the IBC array (Table 3) displaying the
smallest heterogeneity P-values. Heterogeneity in the associ-
ation results across studies may have attenuated association
P-values, but also revealed mechanisms of action of genetic
variants on blood pressure.
We did not observe clear replication of our two top loci that
were genome-wide significant in our CARe GWAS. Our repli-
cation cohorts were generally small thus reducing the power to
replicate significant findings. We estimated the proportion of
variation in blood pressure associated with the two genome-
wide significant SNPs at 0.4% in CARe samples. Because
of the winner’s curse and the variation in LD between a true
causal SNP and our identified SNP, our effect size may be
overestimated, which may contribute to failure to replicate.
In addition, population admixture may result in different LD
patterns for the African-American samples from different geo-
graphical regions because the LD is dependent on the admix-
ture proportion. It has been reported that the admixture
proportion rate is different across the African-American popu-
lation (26,27). Thus, replication analysis can be challenging in
African-American populations.
These limitations are leveraged against the advantage of
using large community-based cohorts of AAs for this analysis
and the implementation of quality-control procedures in indi-
vidual examination centers and the harmonization of imputa-
tion strategies and analytical methods.
CONCLUSIONS
We found evidence of genetic influences on SBP and DBP.
Evidence of association in our GWAS was found for DBP
(rs10474346 on chromosome 5 near GPR98 and ARRDC3)
and for SBP (rs2258119 on chromosome 21in C21orf91).
Caution should be paid because the two top SNPs identified
in CARe GWAS were not replicated in independent cohorts
of African ancestry, and further replication efforts with large
sample size are warranted.
Of note, several previously reported EA blood pressure
SNPs did replicate in our CARe AA samples. These SNPs
are in the regions of SH2B3, TBX3-TBX5 and CSK-ULK3.
Implications
We identified genetic variants that reached genome-wide sig-
nificance for SBP and DBP in a large number of AAs from theT
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CARe consortium that did not replicate in a meta-analysis of
cohorts of African ancestry. To our knowledge, these genetic
loci represent the best evidence of genetic influences on SBP
and DBP in AAs to date. Hypertension represents the
leading cause of death from cardiovascular disease in AAs.
Our study lends support to prior admixture analyses, which
indicate that blood pressure represents a complex disease
trait with genetic underpinnings within the AA community.
Further investigation of the genetic loci identified in our analy-
sis including replication efforts is warranted. Identification of
potential genetic loci implicated in hypertension represents a
unique opportunity to introduce new treatment and manage-
ment strategies for this high-risk population.
MATERIALS AND METHODS
Study sample
NHLBI’s CARe Study includes six cohort studies with AA
representation: the ARIC Study, the CHS, the CARDIA, the
CFS, the JHS and MESA (see Supplementary Material,
Section I, for sampling details). Each study adopted collabor-
ation guidelines and established a consensus on phenotype
harmonization, covariate selection and an analytical plan for
within-study genetic association and prospective
meta-analysis of results across studies. Each study received
institutional review board approval of its consent procedures,
examination and surveillance components, data security
measures and DNA collection and its use for genetic research.
All participants in each study gave written informed consent
for participation in the study, and the conduct of genetic
research. AA samples from five cohorts (ARIC, CARDIA,
CFS, JHS and MESA) had genome-wide genotyping using
the Affymetrix Genome-Wide Human SNP Array 6.0 array
and blood pressure data for association analysis. Six cohorts
(ARIC, CARDIA, CFS, CHS, JHS and MESA) had candidate
gene genotyping in AAs using the Illumina iSelect
HumanCVD bead array (28). We excluded individuals
younger than 18 years of age.
Genotyping and quality control
Quality control of genotyping data was performed using
PLINK (29). Quality-control efforts were conducted at two
levels: exclusion of individuals and exclusion of SNPs.
Samples with a genotyping success rate of ,95% were
removed. An inbreeding coefficient was calculated and used
as a measure of heterozygosity. Outliers for heterozygosity
(defined as less than 24 SD or .4 SD beyond the mean)
were removed because of possible DNA contamination or
poor DNA quality. For population-based cohorts, pair-wise
identity-by-descent score was calculated and for each pair of
identical samples, the sample with the lowest genotyping
success rate was removed. In addition, samples that shared
5% or more of their genome with other samples also were
excluded. Multidimensional scaling (MDS) was used to esti-
mate population substructure and the identified outliers were
removed.
There were 1176 SNPs that mapped to more than one locus
in the human genome that were excluded from analysis. Indi-
vidual SNPs were also excluded if they had a call rate of less
than 90% or were monomorphic. For family data, Mendelian
inconsistency was checked using PLINK and the correspond-
ing SNPs were removed. No SNPs were removed due to sig-
nificant deviation from Hardy–Weinberg equilibrium (HWE)
because the African-American population is an admixed popu-
lation, which may result in departure from HWE.
Genotype imputation
SNP imputation was performed using MACH and the HapMap
phase 2 data sets (build 36 release 22) employing a similar
strategy as that used by Kang et al. (9). In order to address
the admixture component of our African-American popu-
lation, a reference panel consisting of equal proportions of
the YRI and CEU HapMap-phased haplotypes (using only
SNPs found in both YRI and CEU panels, i.e. 2.2 million
SNPs) was constructed. Because the CARe project had both
IBC array and Affymetrix 6.0 data genotypes on the 8500
individuals of African ancestry, it was possible to assess the
Table 4. Meta-analysis of CARe and additional African-origin cohorts, as well as the P-values in ICBP
SNP ID Chr Position Type Nearest gene SBP DBP
Meta P ICBP P Meta P ICBP P
rs10474346 5 90 599 895 Affy6 Imputed GPR98/ARRDC3 9.96 × 1023 5.19 × 1021 1.02 × 1023 5.65 × 1021
rs13413144 2 153 183 499 Affy6 Imputed FMNL2 9.28 × 1024 4.22 × 1021 1.06 × 1021 8.00 × 1021
rs17610514a 11 55 652 374 CARDIA Olfactory 8.50 × 1025 2.59 × 1021 3.90 × 1025 2.20 × 1021
rs1990151 1 44 186 879 Affy6 Genotyped IPO13 1.14 × 1023 8.20 × 1021 8.63 × 1023 8.14 × 1021
rs2012318 19 19 069 240 IBC Genotyped SLC25A42 5.68 × 1026 5.92 × 1021 6.21 × 1023 6.04 × 1021
rs214070b 11 17 261 893 IBC Genotyped NUCB2 NA 3.23 × 1022 NA 1.67 × 1022
rs2258119 21 18 089 350 Affy6 Genotyped C21orf91 5.00 × 1024 5.28 × 1021 1.41 × 1022 6.54 × 1021
rs592582 2 157 481 632 Affy6 Imputed GPD2 9.15 × 1023 9.16 × 1021 1.22 × 1021 6.59 × 1021
rs7709572 5 90 592 789 Affy6 Genotyped GPR98 1.38 × 1022 4.56 × 1021 6.49 × 1024 5.68 × 1021
Meta P, P-value by combining all cohorts of African ancestry;
ICBP P, one-sided P-value in ICBP data. For SNPs genotyped in Affy6, P-value, 5 × 1028 is considered as statistically significant. For SNPs genotyped in IBC
chip, P-value ,2 × 1026 is considered as statistically significant.
aSNP rs17610514, failed WHI QC due to low concordance rate among duplicates (,98%) and/or low call rate (,95%) and thus was not included in the
meta-analysis.
bSNP rs214070 was not genotyped in the cohorts of African ancestry except CARe.
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Table 5. Lookup of top SNPs for SBP and DBP from the meta-analysis of CHARGE and Global BPgen
SNP identifier Chr Position Nearest gene Alleles
(coded/other)
CHARGE + Global BPgen
meta-analysis
CARe meta-analysis, DBP CARe meta-analysis, SBP
Beta SE P-value Effect
allele
Other
allele
Effect P-value Effect
allele
Other
allele
Effect P-value
SBP
rs12046278a 1 10 722 164 CASZ T/C 20.53 0.12 4.77 × 1026 C T 0.40 0.23 C T 0.06 0.92
rs7571613a 2 190 513 907 PMS1 A/G 20.54 0.13 1.90 × 1025 G A 20.16 0.46 G A 20.28 0.45
rs448378 3 170 583 593 MDS1 A/G 20.51 0.10 1.18 × 1027 A G 0.15 0.42 A G 0.13 0.68
rs2736376a 8 11 155 175 MTMR9 C/G 20.48 0.15 9.15 × 1024 C G 20.31 0.13 C G 20.47 0.18
rs1910252a 8 49 569 915 EFCAB1 T/C 20.43 0.13 6.13 × 1024 T C 0.03 0.90 T C 20.23 0.51
rs11014166a 10 18 748 804 CACNB A/T 0.50 0.10 7.03 × 1027 T A 20.20 0.44 T A 20.30 0.50
rs1004467a 10 104 584 497 CYP17A A/G 1.05 0.16 1.28 3 10210 G A 0.01 0.97 G A 20.31 0.48
rs381815 a 11 16 858 844 PLEKHA T/C 0.65 0.11 1.89 3 1029 T C 0.41 0.07 T C 0.62 0.10
rs2681492a 12 88 537 220 ATP2B1 T/C 0.85 0.13 3.76 3 10211 C T 20.18 0.54 C T 20.22 0.65
rs3184504a 12 110 368 991 SH2B3 T/C 0.58 0.10 4.52 3 1029 T C 0.53 0.14 T C 1.61 9.13 × 1023
DBP
rs13423988a 2 68 764 770 GPR73-ARHGAP25 T/C 0.33 0.08 5.00 × 1025 T C 20.10 0.62 T C 0.08 0.81
rs13401889a 2 190 618 804 MST T/C 20.31 0.08 4.82 × 1025 T C 20.01 0.94 T C 0.16 0.63
rs9815354a 3 41 887 655 ULK4 A/G 0.49 0.08 2.54 3 1029 A G 0.16 0.49 A G 0.26 0.40
rs7016759 8 49 574 969 EFCAB1 T/C 0.30 0.08 2.29 × 1024 C T 20.27 0.50 C T 20.64 0.44
rs11014166a 10 18 748 804 CACNB2 A/T 0.37 0.06 1.24 3 1028 T A 20.20 0.44 T A 20.30 0.50
rs11024074 11 16 873 795 PLEKHA7 T/C 20.33 0.07 1.20 × 1026 C T 0.45 0.20 C T 0.52 0.13
rs2681472a 12 88 533 090 ATP2B A/G 0.50 0.08 1.47 3 1029 G A 20.40 0.20 G A 20.61 0.25
rs3184504a 12 110 368 991 SH2B3 T/C 0.48 0.06 2.58 3 10214 T C 0.53 0.14 T C 1.61 9.13 × 1023
rs2384550 12 113 837 114 TBX3-TBX5 A/G 20.35 0.06 3.75 3 1028 A G 20.35 0.07 A G 20.75 0.03
rs6495122a 15 72 912 698 CSK-ULK3 A/C 0.40 0.06 1.84 3 10210 C A 20.51 0.02 C A 21.32 3.74 × 1024
SNPs in boldface attained P , 5 × 1028 in meta-analysis of CHARGE and Global BPgen.
aResults of SNPs are from imputed SNPs.
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quality of the imputation process. The observed concordance
was 95.6%, which is comparable to previous studies (30).
Imputation was performed for the Affymetrix 6.0 data only.
Phenotype modeling
SBP and DBP were modeled at the first examination for ARIC,
CHS, MESA and JHS, and at the most recent examination for
CARDIA and CFS in order to minimize the effect of extreme
age differences between the cohorts. For ARIC and JHS,
seated blood pressure was measured with a random-zero
sphygmomanometer three times with the last two measure-
ments averaged. For CARDIA, seated BP was measured on
the right arm following 5 min rest using a random-zero sphyg-
momanometer. SBP and DBP were recorded as Phase I and
Phase V Korotkoff sounds. Three measurements were taken
at 1 min intervals with the average of the second and third
measurements taken as the blood pressure value. For CFS,
blood pressure was measured using a mercury sphygmoman-
ometer and was the average of nine readings (three each
made over three intervals in an 18 h period). Three measures
were made supine before bed, three measures were made
awake supine after bed and three were measured awake
while sitting. For MESA, resting seated blood pressure was
measured three times at 1 min intervals using an automated
oscillometric sphygmomanometer (Dinamap PRO 100, Criti-
kon); the average of the second and third blood pressure
measurements was used for these analyses. For individuals
taking antihypertensive medication, we added 10 and
5 mmHg to the measured SBP and DBP (31), respectively,
to account for treatment effect. Continuous DBP and SBP
were adjusted for age, age2, sex and body mass index (BMI)
in linear regressions. Residuals were calculated and
applied within cohort for analysis of genotype–phenotype
associations.
Statistical analyses
Within each cohort, the first 10 main eigenvectors from prin-
cipal components (PCs) were calculated and included in the
model testing genotype–phenotype association. The PCs
were calculated based on selected ancestry informative
markers. For comparison, we also calculated the PCs using
the method described in Zhu et al. (8), in which the eigenvec-
tors were calculated based on only unrelated individuals. PCs
were then calculated for all individuals, including family
members. Additionally in this method, all SNPs were used
to calculate PCs. The results between the two methods were
consistent, except for a few individuals (Supplementary
Material, Figure S2). We did not find that the discrepancy
affected final association results. For all data sets except
CFS, which includes family data sets, association of SNPs
with SBP and DBP was tested by linear regression with addi-
tive genetic model using PLINK; for CFS, association was
tested using a linear mixed-effect model that accounted for
family structure (32).
Meta-analysis of results was carried out using the inverse-
variance weighting method in METAL (http://www.sph.um
ich.edu/csg/abecasis/metal/). Genomic control was carried
out on cohort-specific test statistics and used to adjust results
within each study.
For comparison, analysis of pooled raw data from the five
cohorts genotyped with the Affymetrix 6.0 array was carried
out with FamCC (8). Cohort-specific genotypes and standar-
dized DBP or SBP residuals were pooled together. PCs were
calculated for all unrelated individuals and predicted for
related individuals. Genotype–phenotype association was
tested using a linear regression model with adjustment for
the first 10 PCs.
Previously published genome-wide significant SNP associ-
ations with blood pressure 7, 9 and 10 were examined. If the
published SNPs were not available in either genotyped SNPs
or imputed SNPs in the current study, we used SNPs in a
strong LD with the sentinel SNPs as proxies.
Loci with a P-value of ,1 × 1026 for the GWAS data and
of ,1 × 1025 for IBC data were selected for replication
analysis in independent cohorts of African and European
ancestry. SNPs in LD (r2 ≥ 0.5) were considered to represent
the same signal; consequently, the SNP with the smallest
P-value at a locus was selected for replication analysis.
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I. CARE Study Cohort Descriptions 
The  Atherosclerosis Risk in Communities (ARIC) Study initiated in 1987 and was 
designed to investigate the cause and natural history of CVD in for United States communities. 
Study design and procedures were reported extensively.(1) At the Jackson, Mississippi, field 
center, only African-Americans were recruited. The institutional review board at each of the 
study sites approved the study protocols, and written informed consent was obtained from all 
participants.   
The Cardiovascular Health Study (CHS) is a longitudinal study of 5888 participants 
(3393 women and 2495 men) > 65 years old. The initial cohort of CHS participants was recruited 
between April 1989 and May 1990 from four US communities: Forsyth County, North Carolina; 
Sacramento County, California; Washington County, Maryland; and Pittsburgh, Pennsylvania. 
The original cohort consisted of 5201 participants that were primarily of European ancestry: 148 
(3%) were African American women and 96 (1.8%) were African American men. A second 
cohort of 687 African Americans (431 women and 256 men) was enrolled between June 1992 
and June 1993.(2,3) The institutional review board at each of the study sites approved the study 
protocols, and written informed consent was obtained from all participants.   
The Cleveland Family Study (CFS) participants consists of first or selected second-
degree relatives of a proband with either laboratory diagnosed obstructive sleep apnea or 
neighborhood control of an affected proband. Families were selected for genotyping on the 
basis of genetic informativity, including multigenerational data or individuals from the extremes 
of the distribution of apnea phenotype. (4,5) These families include 59 African-American families 
with 176 individuals (100 females and 76 males) and 66 European-American families with 262 
individuals (120 females and 142 males) with genotype and phenotype information. The 
institutional review board approved the study and written informed consent was obtained from all 
participants.   
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The Coronary Artery Risk Development in Young Adults (CARDIA) study began in 
1985 to focus on the development and progression of coronary disease in young adults. The 
CARDIA study initial enrollment consisted of 5115 European Americans and African American 
men and women between 18 and 30 years old (52% African American and 55% women).  The 
study is multicenter with recruitment in Birmingham, AL; Chicago, IL; Minneapolis, MN; and 
Oakland, CA. The institutional review board at each of the study sites approved the study 
protocols, and written informed consent was obtained from all participants.  Baseline 
measurements were repeated, and additional measurements performed, at years 2, 5, 7, 10, 15, 
and 20.(6) 
The community-based Jackson Heart Study (JHS) was initiated in 2000 to investigate 
prospectively the epidemiology and determinants of cardiovascular disease in African 
Americans.(7)  JHS recruited 5,302 participants after completion of data adjustment, 
representing more than 5% of African Americans 35-84 years old living in the Jackson, MS tri-
county area.  Of this number, approximately 30% were prior Jackson participants in the 
Atherosclerosis Risk in Communities Study.  Of the remaining, 23% were recruited by random 
selection from a commercial listing that represents the overall tri-county population and an 
additional 23% volunteer sample, in which recruitment was distributed among defined 
demographic cells in proportions designed to mirror those in the overall population.(8) Those 
who were overlapping ARIC participants and those with previous MI were excluded from the 
GWAS.  The institutional review board approved the study protocol, and written informed 
consent was obtained from all participants.   
The Multi-Ethnic Study of Atherosclerosis Study (MESA) Study is a multicenter 
prospective cohort study initiated to study the development of subclinical cardiovascular 
disease.  A total of 6814 women and men between the age of 45 and 84 year were recruited for 
the first examination between 2000 and 2002.  Participants were recruited in six US cities 
(Baltimore, MD; Chicago, IL; Forsyth County, NC; Los Angeles County, CA; Northern 
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Manhattan, NY; and St. Paul, MN).   Approximate 38% and 28% were European American and 
African American respectively.  Those with a history of CVD (defined as physician-diagnosed 
myocardial infarction, angina, heart failure, stroke, transient ischemic attack or history of 
invasive procedure for CVD) were excluded from participation. This study was approved by the 
institutional review boards of each study site, and written informed consent was obtained from all 
participants.(9) 
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 Replication Cohort Descriptions 
The Maywood African-American cohort is composed of 775 individuals from Maywood, IL. A 
total of 743 individuals were included in this analysis. DNA samples were obtained from a larger 
cohort of families enrolled in studies of blood pressure at Loyola University in Maywood, Illinois. 
The survey enrolled a representative random sample of the population between the ages of 18-
74, regardless of obesity phenotype. A subcohort of unrelated participants was selected and 
oversampled at the upper and lower ends of the BMI distribution to increase power. SBP, DBP, 
medication history, BMI were collected. All the individuals were genotyped with Affymetrix 
Genome-Wide human SNP array 6.0 at Broad Institute. The detailed QCs were described  in 
Kang et al.(10) The project was reviewed and approved by the IRBs at Loyola University 
Chicago and Case Western Reserve University. All participants gave written informed consent.  
The sampling frame for the International Collaborative Study on Hypertension in 
Blacks (ICSHIB) as described in detail elsewhere.(11) Study participants were recruited from 
Igbo-Ora and Ibadan in southwest Nigeria as part of a long-term study on the environmental and 
genetic factors underlying hypertension. The sample comprised 1098 unrelated adults with 
normal or elevated blood pressure and 155 unrelated participants from Ibadan with elevated 
blood pressure recruited as controls in the Africa-America Diabetes Mellitus (AADM) Study.(12) 
A total of 1188 individuals were included in this analysis. Both projects were reviewed and 
approved by the IRBs of the sponsoring US institutions (Loyola University Chicago and Howard 
University) and the University of Ibadan. All participants gave written informed consent 
administered in either English or Yoruba. Phenotype measurements were taken during a 
screening exam completed by trained research staff using a standardized protocol.(13)  All the 
individuals were genotyped with Affymetrix SNP array.  The detailed QCs detailed 
elsewhere.(10) 
 The Howard University Family Study (HUFS) is a population-based family study of 
African Americans in the Washington DC metropolitan area.  Investigators enrolled a randomly 
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recruited a set of families in addition to a set of unrelated individuals to study genetic and 
environmental relation of common complex diseases including hypertension.  The institutional 
review board approved the study protocol, and written informed consent was obtained from all 
participants.  A total of 1016 individuals were included in this analysis. Three BP were measured 
ten minutes apart in the sitting position using an Omron oscillometric device.   The report SBP 
and DBP was the average of the second and third readings.(14)  
 The Genetic Epidemiology Network of Arteriopathy (GENOA) is one of the four 
networks in the Family Blood Pressure Program. GENOA recruited hypertensive black and non-
Hispanic white sibships for linkage and family-based association studies to investigate genetic 
contributions to blood pressure and the cardiac and renal complication of hypertension in 
multiple racial groups.(15)  Participant recruitment for GENOA (Exam 1, 1995-2000 and Exam 
2, 2000-2005) was population-based in 2 geographic locations: Jackson, Mississippi and 
Rochester, Minnesota.  African Americans in the study were located solely at the GENOA 
Jackson field center. Hypertensive probands were ascertained from the Jackson cohort of the 
Atherosclerosis Risk in Communities (ARIC) Study if they were in a sibship with ≥ 2 individuals 
with essential hypertension (systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg on the second 
and third clinic visit), diagnosed prior to age 60, and were willing to be recruited.  Those index 
sibpairs with possible secondary hypertension (including sibpairs with previously diagnosed 
kidney disease (defined by serum creatinine level > 2 mg/dL)) were excluded.  A total of 845 
individuals were included in this analysis. The institutional review board at each of the study 
sites approved the study protocols, and written informed consent was obtained from all 
participants.   
The Women Health Initiative (WHI) cohort is a multicenter study (40 US clinical centers) of 
women aged 50 to 79 years consisting of overlapping clinical trials and an observation study.  
An initial sample of 98,705 were recruited at baseline between September 1993 and the end of 
February 1997. A total of 8090 African American women were included in this analysis.  
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Recruitment was mostly by mass mailing to age-eligible women.  Recruitment of minorities and 
older women was a particular study objective.  In WHI, SBP and DBP were measured at the first 
screening clinic visit in the right arm with a conventional mercury sphygmomanometer after the 
participant sat quietly for 5 minutes.   The average of 2 readings, obtained at least 30 seconds 
apart, was used for analysis. The institutional review board at each of the study sites approved 
the study protocols, and written informed consent was obtained from all participants.   
  The International Consortium for Blood Pressure Genome-wide Association 
Studies (ICBP GWAS) represents a union of two prior blood pressure GWAS consortia (16,17) 
to create a discovery meta-analysis of 69,899 individuals of European ancestry with GWAS.  
ICBP tested for association of 2.5 million HapMap SNPs with SBP and DBP. For individuals 
receiving antihypertensive medications 15 mm Hg and 10 mm Hg were added to the observed 
SBP and DBP in order to account for treatment effect. An additive genetic model was used in 
GWAS of individual participant data within each member cohort and meta-analysis was 
performed using inverse variance weighting. 
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 Lookup Cohorts Descriptions 
Adebowale et al. performed the first GWAS for blood pressure phenotypes among African 
Americans.  This study consisted of a case-control study of hypertension among 1,017 African 
Americans from the Washington, D.C. No SNP reached genome wide significance for 
association with hypertension or DBP. However among the 508 normotensive controls, six 
SNPs, reached genome-wide significance with SBP. The SNPs were in or near the following 
genes: PMS1, AL365265.23 (a pseudogene), SLC24A, YWHAZ, IPO7, and CACNA1H. 
Subsequently, the investigators performed two replication studies. In a hypertension case-
control study consisting of 980 West Africans, three of the six SNPs were monomorphic. The 
other three SNPs were not associated with blood pressure phenotypes. 
The CHARGE Consortium consists of 29,136 participants of European descent from six 
population-based cohort studies. Forty-three SNPs representing 7 loci on 4 chromosomes were 
associated with a blood pressure phenotype with a P value < 4 x 10-7. Six SNPs from 4 of the 
loci were tested for replication in 34,433 individuals representing the Global BPgen Consortium. 
Five of the six SNPs representing three loci achieved criteria consistent with external replication. 
All three loci were located on chromosome 12 and include ATP2B1, TBX3-TBX5, and a large 
block of linkage disequilibrium on 12q24 including SH2B3, ATXN2, TRAFD1 and other genes. 
Finally, 30 SNPs were tested for association with blood pressure phenotypes in a joint meta-
analysis of CHARGE and Global BPgen. Eleven SNPs representing eight loci attained a 
genome-wide significance level of P < 5 x 10-8. Genes at these loci included CYP17A1, 
PLEKHA7, ATP2B1, SH2B3, CACNB2, CSK-ULK3, TBX3-TBX5, and ULK4.  
The Global BPgen Consortium consisted of 34,433 individuals of European ancestry from 
17 cohorts ascertained through population-based sampling or from case-control studies. The 
investigators identified 26 SNPs that were associated with a blood pressure phenotype at the p 
< 1 x 10-8 level. Twelve SNPs were then carried forward in a meta-analysis including up to 
71,225 individuals of European descent. SNPs in 5 loci were significant at p < 5 x 10-8. These 
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loci contained the genes MTHFR/NPPA, CYP17A1, FGF5, ATXN2/SH2B3, and CYP1A2. 
Twenty SNPs were then tested for replication in the 29,136 individual of European descent 
representing the CHARGE Consortium. SNPs in 8 loci were significant at the 5 x 10-8 level. 
These loci contained CYP17A1, CYP1A2, FGF5, SH2B3/ATXN2, MTHFR/NPPA, c10orf107, 
ZNF652, and PLCD3.   
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II.  Supplemental Tables and Figures 
 
Supplementary Figure 1A, 1B, 1C. QQ plots of all SNPs for the African Americans from 
Affymetrix 6.0 arrays for each of the CARe cohorts for DBP (Figure 1A) and SBP (Figure 1B); 
QQ plots and Manhattan plots for the meta-analysis results of the African Americans from 
Affymetrix 6.0 arrays for DBP (Figure 1C) and SBP (Figure 1D). 
 
 
Figure 1A.  Cohort-specific QQ plots for DBP 
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Figure 1B.  Cohort-specific QQ plots for SBP 
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Figure1C. Meta-analysis QQ plot and Manhattan plot for DBP 
 
 
Figure1D. Meta-analysis QQ plot and Manhattan plot SBP 
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Supplementary Figure 2 Comparison of the 1st and 2nd principal components calculated using 
FamCC 
 
Within each cohort, the first ten main eigenvectors from principal components (PCs) were 
calculated and included in the model testing genotype-phenotype association. The PCs were 
calculated based on selected ancestry informative markers.  For comparison, we also calculated 
the PCs using the method described in Zhu et al. (Fam CC) in which the eigenvectors were 
calculated based on only unrelated individuals. PCs were then calculated for all individuals, 
including family members. The results between the two methods were consistent. 
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Supplementary Table 1. Top SNPs for DBP in CARDIA cohort genotyped with Affymetrix 6.0 
 
In African Americans in the CARDIA cohort only, we observed a strong association signal in a 1.26Mb region on chromosome 11 
(smallest P=3.95×10-9 for rs17610514). 
CHR SNP BP A1 A1_FREQ BETA STDERR STAT P 
11 rs7127405 54889359 A 0.99 -12.59 2.82 -4.47 8.96×10-6 
11 rs1364762 54954489 C 0.99 -11.46 2.53 -4.53 6.62×10-6 
11 rs17578661 54961901 C 0.98 -10.97 2.37 -4.63 4.14×10-6 
11 rs17494990 55034337 C 0.01 14.27 2.76 5.17 3.02×10-7 
11 rs17579895 55034676 G 0.99 -11.81 2.58 -4.58 5.28×10-6 
11 rs17581532 55078399 A 0.011 14.47 2.84 5.10 4.24×10-7 
11 rs7951100 55346872 G 0.99 -12.83 2.52 -5.09 4.36×10-7 
11 rs17594092 55379538 C 0.99 -11.33 2.40 -4.72 2.76×10-6 
11 rs12098941 55423019 A 0.02 10.97 2.19 5.00 7.04×10-7 
11 rs12098903 55423089 A 0.98 -10.98 2.19 -5.01 6.78×10-7 
11 rs12098904 55423129 A 0.98 -12.8 2.35 -5.46 6.44×10-8 
11 rs17510438 55426891 A 0.02 10.97 2.19 5.00 7.04×10-7 
11 rs17510445 55426966 A 0.99 -12.04 2.50 -4.81 1.76×10-6 
11 rs17511107 55432601 C 0.02 12.27 2.31 5.32 1.34×10-7 
11 rs17596143 55434921 A 0.02 10.97 2.19 5.00 7.04×10-7 
11 rs17511601 55437951 G 0.02 10.97 2.19 5.00 7.04×10-7 
11 rs17597169 55445686 C 0.02 11.21 2.08 5.38 9.88×10-8 
11 rs17597302 55446439 C 0.98 -10.97 2.19 -5.00 7.04×10-7 
11 rs17512592 55446818 A 0.98 -10.97 2.19 -5.00 7.04×10-7 
11 rs7936086 55447435 C 0.98 -10.97 2.19 -5.00 7.04×10-7 
11 rs9666086 55460226 A 0.97 -8.266 1.71 -4.83 1.65×10-6 
11 rs17598045 55464867 A 0.02 10.71 2.03 5.28 1.65×10-7 
11 rs17598094 55465391 C 0.03 9.181 1.77 5.18 2.84×10-7 
11 rs17513829 55472273 A 0.03 7.943 1.70 4.68 3.42×10-6 
11 rs17599023 55478053 C 0.03 8.081 1.79 4.51 7.36×10-6 
11 rs17514414 55478916 C 0.03 8.213 1.77 4.64 4.12×10-6 
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11 rs17599408 55482226 A 0.97 -8.22 1.77 -4.66 3.84×10-6 
11 rs17599471 55483185 A 0.03 9.15 1.80 5.10 4.25×10-7 
11 rs17527788 55503589 C 0.97 -9.88 1.85 -5.34 1.23×10-7 
11 rs1384089 55605592 C 0.03 10.56 1.85 5.72 1.53×10-8 
11 rs17602278 55605691 C 0.03 10.77 1.85 5.84 7.71×10-9 
11 rs17530228 55605732 A 0.97 -10.01 1.79 -5.60 2.91×10-8 
11 rs17530318 55607598 A 0.03 11.04 1.87 5.92 4.79×10-9 
11 rs7943453 55616001 A 0.03 10.56 1.85 5.72 1.53×10-8 
11 rs7929570 55633829 C 0.02 12.98 2.19 5.94 4.25×10-9 
11 rs7935728 55636031 C 0.97 -11.06 1.87 -5.93 4.55×10-9 
11 rs17603373 55642795 C 0.01 14.75 2.73 5.40 9.02×10-8 
11 rs17531933 55652225 C 0.03 10.00 1.79 5.59 3.17×10-8 
11 rs17531954 55652307 C 0.03 10.01 1.79 5.60 2.91×10-8 
11 rs17610514 55652374 A 0.97 -10.49 1.76 -5.95 3.95×10-9 
11 rs7108801 55833176 C 0.97 -9.819 1.83 -5.37 1.04×10-7 
11 rs1807254 56020115 A 0.01 12.04 2.50 4.81 1.76×10-6 
11 rs1876924 56104212 A 0.01 14.35 2.47 5.80 9.31×10-9 
11 rs7925450 56108078 C 0.011 12.01 2.50 4.80 1.91×10-6 
11 rs17630698 56152574 G 0.01 12.04 2.50 4.81 1.76×10-6 
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Supplementary Table 2.  Look-up of top SNPs for SBP and DBP from three published studies. Results of SNPs names labeled with * 
are from imputed SNPs.  Table 2A. Plos Genetics (HUFS)(14), Table 2B. Nature Genetics (Global BP gen)(17), and manuscript Table 
5. Nature Genetics (CHARGE + Global BP gen)(16).    
 
One large scale GWAS in individuals of African ancestry (HUFS)(14) and two large scale GWAS in individuals of European ancestry 
(CHARGE and Global BP gen)(16,17) have been published.  We performed look-up of top SNPs for SBP and DBP from these three 
published studies in our cohort. We found no replication of the SNPs from HUFS in our cohort. We replicated 3 SNPs identified in 
individuals of European Ancestry [rs3184504 (SH2B3, one-sided P=0.009), rs2384550 (TBX3-TBX5, one-sided P=0.03) and 
rs6495122 (CSK-ULK3, one-sided P=0.0004)].    
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Table 2A.  
 
 
 
 
 
 
Rank  SNP  Chr  Position  Type  Closest gene  
Distance 
to gene 
(kb)  
HUFS analysis 
 
CARe meta-analyis , DBP  
 
CARe meta-analyis , SBP  
Allele MAF P 
 Effect 
allele  
Other 
Allele  Effect  P  
 
Effect  
allele  
Other 
Allele  Effect  P  
Systolic BP  
        
 
         
1  rs5743185  2  190446083  INTRONIC  PMS1  0  T  0.14  2.09×10-11   A G 1.48 0.54 
 
A G 2.30 0.50 
2  rs16877320  6  16031005  INTERGENIC  AL365265.23  12  G  0.13  3.42×10-9   C T -1.12 0.07 
 
C T -1.26 0.23 
3  rs11160059  14  91877083  INTRONIC  SLC24A4  0  A  0.18  1.54×10-8   T C 0.21 0.63 
 
T C 0.69 0.34 
4  rs17365948*  8  102026053  INTRONIC  YWHAZ  0  A  0.11  1.59×10-8   T C 0.53 0.53 
 
T C 0.68 0.64 
5  rs12279202  11  9388666  INTRONIC  IPO7  0  A  0.12  4.80×10-8   T C 1.17 0.16 
 
T C 3.03 0.03 
6  rs3751664  16  1194370  NON_SYNONYMOUS_CODING  CACNA1H  0  T  0.11  6.71×10-8   NA  NA  NA  NA  
 
NA  NA  NA  NA  
7  rs11659639*  18  56318592  INTERGENIC  MC4R  127  C  0.10  2.13×10-7   G T -1.41 0.41 
 
G T -3.04 0.28 
8  rs4613079  16  79201458  INTRONIC  CDYL2  0  T  0.18 5.06×10-7   A G 0.04 0.94 
 
A G 1.24 0.21 
9  rs13201744  6  6071844  INTERGENIC  F13A1  17  A  0.16  1.12×10-6   A C -1.20 0.03 
 
A C -0.29 0.76 
10  rs2183737  9  70431453  INTERGENIC  RP11-274B18.3  15  T  0.46  1.21×10-6   A G 0.29 0.13 
 
A G 0.30 0.36 
Diastolic BP  
        
 
         
1  rs1867226  15  89324717  INTRONIC  PRC1  0  C  0.46 5.80×10-7   C G -0.15 0.43 
 
C G -0.11 0.74 
2  rs9590141  13  94401623  INTERGENIC  ABCC4  68  A  0.12  8.76×10-7   A G -0.02 0.94 
 
A G 0.23 0.65 
3  rs10135446  14  79479231  INTERGENIC  NRXN3.  79  A  0.13  4.47×10-6   T G 0.29 0.28 
 
T G 0.86 0.05 
4  rs11120313  1  212647829  INTRONIC  PTPN14  0  A  0.16  4.53×10-6   A C 0.09 0.71 
 
A C 0.25 0.55 
5  rs16848861  1  235211537  INTERGENIC  RP11-182B22.4  0  G  0.20  4.73×10-6   G A 0.19 0.42 
 
G A 0.87 0.03 
6  rs11846013  14  46002041  INTERGENIC  RPL10L  188  A  0.14  4.99×10-6   T G 0.51 0.06 
 
T G 0.21 0.66 
7  rs16853574  3  170562457  INTERGENIC  MDS1  19  C  0.04  5.10×10-6   C T 0.64 0.18 
 
C T 1.59 0.05 
8  rs2823756  21  16664201  INTRONIC  AP000473.2  0  T  0.44 5.73×10-6   A G 0.10 0.61 
 
A G -0.13 0.69 
9  rs8039294  15  89544863  INTRONIC  SV2B  0  G  0.48  6.29×10-6   G T -0.14 0.47 
 
G T -0.18 0.58 
10  rs9301196  13  106645433  INTRONIC  FAM155A  0  T  0.12  6.66×10-6   T C 0.10 0.75 
 
T C 0.05 0.93 
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Table 2B.   
 
BP 
trait SNP Chr Position Type  Closest gene 
 Global BPgen joint analysis 
 
CARe meta-analysis , DBP 
 
CARe meta-analysis , SBP 
Allele Effect se P 
 
Effect 
allele  
Other 
Allele  Effect  P  
 
Effect 
allele  
Other 
Allele  Effect  P  
SBP rs17367504 1 11797044 INTRONIC  MTHFR  G -0.85 0.11 2.00×10-13  G A 0.17 0.58 
 
G A -0.38 0.51 
SBP rs11191548 10 104836168 INTERGENIC  CNNM2/NT5C2  T 1.16 0.12 7.00×10-24  C T -1.06 0.02 
 
C T -0.78 0.30 
SBP rs12946454*  17 40563647 INTRONIC  PLCD3  T 0.57 0.10 1.00×10-8  T A -0.17 0.35 
 
T A -0.57 0.34 
DBP rs16998073*  4 81541520 UPSTREAM  FGF5  T 0.50 0.05 1.00×10-21 
 
T A 0.57 0.14 
 
T A 0.63 0.34 
DBP rs1530440 10 63194597 INTRONIC  c10orf107  T -0.39 0.06 1.00×10-9  T C -0.38 0.42 
 
T C 0.25 0.75 
DBP rs653178 12 110470476 INTRONIC  ATXN2  T -0.46 0.05 3.00×10-18  C T 0.34 0.42 
 
C T 1.75 0.02 
DBP rs1378942 15 72864420 INTRONIC  CSK  C 0.43 0.04 1.00×10-23  A C -0.03 0.92 
 
A C -0.80 0.12 
DBP rs16948048 17 44795465 UPSTREAM  ZNF652   G 0.31 0.05 5.00×10-9  G A 0.09 0.63 
 
G A -0.22 0.49 
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Supplementary Table 3   Top associated SNPs for blood pressure in CARe African Americans from meta-analysis of IBC arrays (P < 
1×10-4) 
 
Meta-analysis of CARe cohorts with IBC chip data did not identify any SNPs that reached the pre-specified array-wide significance 
level based on the estimated effective number of independent tests (SNPs) after adjusting for multiple testing (0.05/25,000=P<2.0×10-
6).  Top SNPs results for DBP were rs2523586 (near HLA-B, P=1.25×10-5) and rs4930130 (near KCNQ1, P=3.16×10-5).  These and 
other SNPs for SBP and DBP with P<10-4 are summarized in this table. 
 
BP 
Trait SNP ID Chr  Position 
Nearest 
Gene 
Effect 
allele 
Effect 
allele 
freq 
Other 
allele 
CARe meta-analysis , DBP   CARe meta-analysis , SBP 
Beta s.e. P 
Heterogeneity 
P   Beta s.e. P 
Heterogeneity  
P 
DBP rs35397 5 33986873 SLC45A2 T 0.21 G 0.90 0.23 8.13×10-5 0.13 
 
0.62 0.38 1.07×10-1 0.00 
DBP rs10068980 5 161220425 GABRA1 A 0.50 G 0.69 0.18 8.83×10-5 0.14 
 
0.46 0.30 1.19×10-1 0.21 
DBP rs2523586 6 31435414 HLA-B G 0.10 T 1.25 0.29 1.25×10-5 0.07 
 
1.13 0.49 2.03×10-2 0.01 
DBP rs10215932 7 150913729 PRKAG2 T 0.07 C 1.30 0.33 7.74×10-5 0.30 
 
1.58 0.55 4.32×10-3 0.23 
DBP rs4930130 11 2576206 KCNQ1 G 0.41 A -0.741 0.18 3.16×10-5 0.29 
 
-0.47 0.30 1.19×10-1 0.18 
DBP rs1791926 11 72621769 P2RY2 C 0.44 T 0.73 0.18 5.53×10-5 0.06 
 
0.69 0.30 2.30×10-2 0.11 
DBP rs285246 19 16281758 KLF2 T 0.23 C 0.83 0.21 7.83×10-5 0.27 
 
0.87 0.35 1.34×10-2 0.47 
SBP rs2270476 2 211234009 CPS1 A 0.11 G 0.97 0.28 6.12×10-4 0.88 
 
1.99 0.48 3.39×10-5 0.28 
SBP rs2232340 3 53866007 IL17RB T 0.04 C -1.03 0.43 1.75×10-2 0.69 
 
-2.90 0.72 5.61×10-5 0.60 
SBP rs2232351 3 53874239 IL17RB G 0.04 A -1.07 0.43 1.28×10-2 0.62 
 
-2.90 0.72 5.13×10-5 0.60 
SBP rs214070 11 17261893 NUCB2 A 0.06 T 0.83 0.40 3.42×10-2 0.16 
 
2.97 0.67 8.65×10-6 0.24 
SBP rs757081 11 17308259 NUCB2 G 0.07 C 0.81 0.37 2.78×10-2 0.16 
 
2.70 0.63 1.76×10-5 0.07 
SBP rs1150226 11 113350751 HTR3A A 0.32 G 0.62 0.19 1.30×10-3 0.24 
 
1.31 0.32 4.51×10-5 0.18 
SBP rs1150219 11 113365953 HTR3A G 0.30 C 0.60 0.19 2.02×10-3 0.65 
 
1.26 0.33 9.95×10-5 0.07 
SBP rs2764626 13 32676469 STARD12 C 0.24 T -0.75 0.20 2.15×10-4 0.54 
 
-1.41 0.34 4.24×10-5 0.75 
SBP rs2012318 19 19069240 SLC25A42 C 0.35 T 0.58 0.19 1.90×10-3 0.09 
 
1.42 0.31 6.42×10-6 0.03 
SBP rs10423742 19 19089136 TMEM161A G 0.32 A 0.57 0.19 3.13×10-3 0.06   1.37 0.32 2.05×10-5 0.16 
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SupplementaryTable 4 (A-L).  Results of replication for systolic and diastolic blood pressure 
by replication cohort and Metaanalysis of African Americans cohorts: Table 4A (Maywood 
systolic blood pressure), Table 4B (Maywood diastolic blood pressure), Table 4C (IC SHIB 
systolic blood pressure), Table 4D (IC SHIB diastolic blood pressure), Table 4E (HUFS systolic 
blood pressure), Table 4F (HUFS diastolic blood pressure), Table 4G (GENOA systolic blood 
pressure), Table 4H (GENOA diastolic blood pressure), Table 4I (WHI systolic blood pressure), 
4J (WHI diastolic blood pressure), 4K (ICBP systolic blood pressure), 4L (ICBP diastolic blood 
pressure). 
 
Replication was attempted for 9 top SNPs identified in genetic association analysis of SBP and 
DBP in CARe African Americans. Criteria for declaring replication was either 0.05/9=5.56 ×10-3 
for cohort specific replication, 5.0 ×10-8 for final meta-analysis of GWAS SNPs or 2.0 ×10-6 for 
final meta-analysis of IBC SNPs.  One top SNP identified for SBP on the IBC array (rs2012318 
in SLC25A42) was replicated in the final meta-analysis (P value of 1.12 ×10-7).  None of the 
other top SNPs from the Affymetrix 6.0 or the IBC array met criteria for replication after 
correcting for multiple comparisons.    
 
 
 
 
Table 4A.  Replication Results for Maywood group (SBP) 
CARe SNPs CHR BP Type A1 A2 A1_FREQ Beta s.e. One-sided P 
rs10474346 5 90599895 Affy6 Imputed C T 0.34 -1.57 1.07 9.29×10-1 
rs13413144 2 153183499 Affy6 Imputed T A 0.06 -0.85 2.55 6.30×10-1 
rs17610514 11 55652374 CARDIA C       T 0.02 4.34 3.79 1.26×10-1 
rs1990151 1 44186879 Affy6 Genotyped A G 0.06 1.86 2.07 1.85×10-1 
rs2012318 19 19069240 IBC Genotyped C T 0.35 1.57 1.06 6.93×10-2 
rs214070 11 17261893 IBC Genotyped       
rs2258119 21 18089350 Affy6 Genotyped C       T 0.32 -1.12 1.13 8.38×10-1 
rs592582 2 157481632 Affy6 Imputed G T 0.38 1.12 1.05 1.43×10-1 
rs7709572 5 90592789 Affy6 Genotyped C       G 0.31 -1.68 1.09 9.40×10-1 
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Table 4B.  Replication Results for Maywood group (DBP) 
CARe SNPs CHR BP Type A1 A2 A1_FREQ Beta s.e. One-sided P 
rs10474346 5 90599895 Affy6 Imputed C T 0.34 -0.50 0.73 7.53×10-1 
rs13413144 2 153183499 Affy6 Imputed T A 0.06 1.41 1.73 2.07×10-1 
rs17610514 11 55652374 CARDIA C T 0.02 1.38 2.58 2.97×10-1 
rs1990151 1 44186879 Affy6 Genotyped A G 0.06 0.51 1.403 3.59×10-1 
rs2012318 19 19069240 IBC Genotyped C T 0.35 0.60 0.72 2.03×10-1 
rs214070 11 17261893 IBC Genotyped       
rs2258119 21 18089350 Affy6 Genotyped C T 0.32 -0.72 0.77 8.27×10-1 
rs592582 2 157481632 Affy6 Imputed G T 0.38 0.45 0.71 2.64×10-1 
rs7709572 5 90592789 Affy6 Genotyped C G 0.31 -0.30 0.74 6.59×10-1 
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Table 4C.  Replication Results for ICSHIB group (SBP) 
CARe SNPs CHR BP Type A1 A2 A1_FREQ Beta s.e. One-sided P 
rs13413144 5 90599895 Affy6 Imputed C T 0.41 -0.22 1.00 5.85×10-1 
rs17610514 2 153183499 Affy6 Imputed T A 0.01 -5.88 5.28 8.65×10-1 
rs1990151 11 55652374 CARDIA C T 0.01 2.38 4.20 2.85×10-1 
rs2012318 1 44186879 Affy6 Genotyped A G 0.07 0.88 1.85 3.18×10-1 
rs214070 19 19069240 IBC Genotyped C T 0.40 2.20 1.05 1.80×10-2 
rs2258119 11 17261893 IBC Genotyped       
rs592582 21 18089350 Affy6 Genotyped C T 0.35 -0.36 1.03 6.35×10-1 
rs7709572 2 157481632 Affy6 Imputed G T 0.32 -0.93 1.03 8.15×10-1 
rs10474346 5 90592789 Affy6 Genotyped C G 0.36 -0.28 1.00 6.12×10-1 
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Table 4D.  Replication Results for ICSHIB group (DBP) 
CARe SNPs CHR BP Type A1 A2 A1_FREQ Beta s.e. One-sided P 
rs10474346 5 90599895 Affy6 Imputed C T 0.41 -0.34 0.57 7.30×10-1 
rs13413144 2 153183499 Affy6 Imputed T A 0.01 -4.01 2.99 9.10×10-1 
rs17610514 11 55652374 CARDIA C T 0.01 1.87 2.38 2.16×10-1 
rs1990151 1 44186879 Affy6 Genotyped A G 0.07 0.12 1.05 4.55×10-1 
rs2012318 19 19069240 IBC Genotyped C T 0.40 0.93 0.59 6.00×10-2 
rs214070 11 17261893 IBC Genotyped       
rs2258119 21 18089350 Affy6 Genotyped C T 0.35 -0.20 0.58 6.36×10-1 
rs592582 2 157481632 Affy6 Imputed G T 0.32 -0.91 0.58 9.40×10-1 
rs7709572 5 90592789 Affy6 Genotyped C G 0.36 -0.41 0.57 7.68×10-1 
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Table 4E.  Replication Results for HUFS Group (SBP) 
CARe SNPs CHR BP Type A1 A2 A1_FREQ Beta s.e. One-sided P 
rs10474346 5 90599895 Affy6 Imputed       
rs13413144 2 153183499 Affy6 Imputed       
rs17610514 11 55652374 CARDIA G A 0.02 3.10 3.48 1.87×10-1 
rs1990151 1 44186879 Affy6 Genotyped A G 0.07 1.22 1.93 2.63×10-1 
rs2012318 19 19069240 IBC Genotyped C T 0.33 0.15 1.09 4.45×10-1 
rs214070 11 17261893 IBC Genotyped       
rs2258119 21 18089350 Affy6 Genotyped C T 0.31 -0.19 1.05 5.70×10-1 
rs592582 2 157481632 Affy6 Imputed G T 0.40 -1.10 1.01 8.60×10-1 
rs7709572 5 90592789 Affy6 Genotyped G C 0.28 -1.50 1.06 9.21×10-1 
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Table 4F.  Replication Results for HUFS group (DBP) 
CARe SNPs CHR BP Type A1 A2 A1_FREQ Beta s.e. One-sided P 
rs10474346 5 90599895 Affy6 Imputed       
rs13413144 2 153183499 Affy6 Imputed       
rs17610514 11 55652374 CARDIA G A 0.02 0.72 2.17 3.71×10-1 
rs1990151 1 44186879 Affy6 Genotyped A G 0.07 -0.11 1.20 5.38×10-1 
rs2012318 19 19069240 IBC Genotyped C T 0.33 -0.25 0.68 6.44×10-1 
rs214070 11 17261893 IBC Genotyped       
rs2258119 21 18089350 Affy6 Genotyped C T 0.31 0.50 0.66 2.24×10-1 
rs592582 2 157481632 Affy6 Imputed G T 0.40 -1.44 0.63 9.89×10-1 
rs7709572 5 90592789 Affy6 Genotyped G C 0.28 -0.94 0.66 9.21×10-1 
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Table 4G.  Replication Results for GENOA  group (SBP) 
CARe SNPs CHR BP Type A1 A2 A1_FREQ Beta s.e. One-sided P 
rs10474346 5 90599895 Affy6 Imputed C T 0.31 1.45 1.19 1.12×10-1 
rs13413144 2 153183499 Affy6 Imputed T A 0.05 0.25 2.68 4.62×10-1 
rs17610514 11 55652374 CARDIA C T 0.02 -0.46 3.82 5.48×10-1 
rs1990151 1 44186879 Affy6 Genotyped A G 0.07 -0.03 2.14 5.06×10-1 
rs2012318 19 19069240 IBC Genotyped C T 0.35 1.52 1.16 9.58×10-2 
rs214070 11 17261893 IBC Genotyped       
rs2258119 21 18089350 Affy6 Genotyped C T 0.33 1.54 1.13 8.60×10-2 
rs592582 2 157481632 Affy6 Imputed G T 0.41 0.39 1.12 3.65×10-1 
rs7709572 5 90592789 Affy6 Genotyped G C 0.27 1.13 1.22 1.79×10-1 
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Table 4H.  Replication Results for GENOA  group (DBP) 
CARe SNPs CHR BP Type A1 A2 A1_FREQ Beta s.e. One-sided P 
rs10474346 5 90599895 Affy6 Imputed C T 0.31 1.53 0.69 1.41×10-2 
rs13413144 2 153183499 Affy6 Imputed T A 0.05 -0.36 1.56 5.91×10-1 
rs17610514 11 55652374 CARDIA C T 0.02 -0.61 2.23 6.08×10-1 
rs1990151 1 44186879 Affy6 Genotyped A G 0.07 0.16 1.25 4.51×10-1 
rs2012318 19 19069240 IBC Genotyped C T 0.35 0.96 0.68 7.81×10-2 
rs214070 11 17261893 IBC Genotyped       
rs2258119 21 18089350 Affy6 Genotyped C T 0.33 -0.20 0.66 6.20×10-1 
rs592582 2 157481632 Affy6 Imputed G T 0.41 -0.27 0.65 6.58×10-1 
rs7709572 5 90592789 Affy6 Genotyped G C 0.27 1.71 0.71 8.40×10-3 
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Table 4I.  Replication Results for WHI (SBP) 
CARe SNPs CHR BP Type A1 A2 A1_FREQ Beta s.e. One-sided P 
rs10474346 5 90599895 Affy6 Imputed C T 0.32 0.02 0.32 4.71×10-1 
rs13413144 2 153183499 Affy6 Imputed T A 0.07 0.43 0.69 2.65×10-1 
rs17610514 11 55652374 CARDIA       
rs1990151 1 44186879 Affy6 Genotyped A G 0.05 -0.16 0.66 5.99×10-1 
rs2012318 19 19069240 IBC Genotyped C T 0.34 0.28 0.31 1.88×10-1 
rs214070 11 17261893 IBC Genotyped       
rs2258119 21 18089350 Affy6 Genotyped C T 0.31 -0.02 0.32 5.20×10-1 
rs592582 2 157481632 Affy6 Imputed G T 0.45 -0.34 0.31 8.65×10-1 
rs7709572 5 90592789 Affy6 Genotyped C G 0.29 0.09 0.32 3.85×10-1 
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Table 4J.  Replication Results for WHI (DBP) 
CARe SNPs CHR BP Type A1 A2 A1_FREQ Beta s.e. One-sided P 
rs10474346 5 90599895 Affy6 Imputed C T 0.32 -0.06 0.17 6.29×10-1 
rs13413144 2 153183499 Affy6 Imputed T A 0.07 -0.16 0.36 6.66×10-1 
rs17610514 11 55652374 CARDIA 
      rs1990151 1 44186879 Affy6 Genotyped A G 0.05 0.36 0.35 1.48×10-1 
rs2012318 19 19069240 IBC Genotyped C T 0.34 0.02 0.17 4.58×10-1 
rs214070 11 17261893 IBC Genotyped 
      rs2258119 21 18089350 Affy6 Genotyped C T 0.31 0.07 0.17 3.35×10-1 
rs592582 2 157481632 Affy6 Imputed G T 0.45 -0.12 0.17 7.61×10-1 
rs7709572 5 90592789 Affy6 Genotyped C G 0.29 -0.01 0.17 5.32×10-1 
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Table 4K.  Replication Results for ICBP (SBP) 
CARe SNPs CHR BP Type A1 A2 A1_FREQ Beta s.e. One-sided P 
rs10474346 5 90599895 Affy6 Imputed C T 0.16 -0.01 0.15 5.19×10-1 
rs13413144 2 153183499 Affy6 Imputed T A 0.24 0.03 0.13 4.22×10-1 
rs17610514 11 55652374 CARDIA G A 0.13 0.11 0.17 2.59×10-1 
rs1990151 1 44186879 Affy6 Genotyped T C 0.13 -0.15 0.16 8.20×10-1 
rs2012318 19 19069240 IBC Genotyped C T 0.18 -0.03 0.13 5.92×10-1 
rs214070 11 17261893 IBC Genotyped A T 0.29 0.20 0.11 3.23×10-2 
rs2258119 21 18089350 Affy6 Genotyped C T 0.19 -0.01 0.12 5.28×10-1 
rs592582 2 157481632 Affy6 Imputed G T 0.89 -0.20 0.14 9.16×10-1 
rs7709572 5 90592789 Affy6 Genotyped G C 0.15 0.02 0.15 4.56×10-1 
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Table 4L.  Replication Results for ICBP (DBP) 
CARe SNPs CHR BP Type A1 A2 A1_FREQ Beta s.e. One-sided P 
rs10474346 5 90599895 Affy6 Imputed C T 0.16 -0.02 0.09 5.65×10-1 
rs13413144 2 153183499 Affy6 Imputed T A 0.24 -0.07 0.08 8.00×10-1 
rs17610514 11 55652374 CARDIA G A 0.13 0.09 0.11 2.20×10-1 
rs1990151 1 44186879 Affy6 Genotyped T C 0.13 -0.09 0.10 8.14×10-1 
rs2012318 19 19069240 IBC Genotyped C T 0.18 -0.02 0.08 6.04×10-1 
rs214070 11 17261893 IBC Genotyped A T 0.29 0.15 0.07 1.67×10-2 
rs2258119 21 18089350 Affy6 Genotyped C T 0.19 -0.03 0.08 6.54×10-1 
rs592582 2 157481632 Affy6 Imputed G T 0.89 -0.04 0.09 6.59×10-1 
rs7709572 5 90592789 Affy6 Genotyped G C 0.15 -0.02 0.09 5.68×10-1 
Supplementary Material: Genome-wide association of Systolic and Diastolic Blood 
Pressure among African Americans:  the Candidate Gene Association Resource (CARe) 
Study 
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